The FDA has announced a voluntary recall of several valsartan-containing heart drugs because they've been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen...
Original Article: Valsartan-Containing Heart Drugs Recalled Due to Possible Cancer Risk